Evaluation of the gene for inducible nitric oxide synthase as a radiosensitizer under hypoxic and oxic conditions

Veterinary and Comparative Oncology

Volumn 5, Issue 4, 2007, Pages 250-255

  Turek, M ^a   Padilla, M ^a   Argyle, David J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cat; Dog; Nitric oxide synthase; Radio gene therapy

Indexed keywords

CANIS FAMILIARIS; CYTOMEGALOVIRUS; FELIDAE;

EID: 68949118151     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2007.00138.x     Document Type: Article

References (14)

1. Howard-Flanders P. Effect of nitric oxide on the radiosensitivity of bacteria. Nature 1957; 180: 1191-1192.
2. Dewey DL. Effect of oxygen and nitric oxide on the radiosensitivity of human cells in tissue culture. Nature 1960; 186: 780-782.
3. Worthington J, Robson T, O'Keefe M and Hirst DG. Tumor cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: A novel suicide gene therapy. Gene Therapy 2002; 9: 263-269.
4. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C and Fidler IJ. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. Journal of Experimental Medicine 1995; 181: 1333-1343.
5. Kurimoto M, Endo S, Hirashima H, Ogiichi T and Takaku A. Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. Journal of Neuro-Oncology 1999; 42: 35-44.
6. Xu W, Liu L and Charles IG. Microencapsulated iNOS-expressing cells cause tumor suppression in mice. Journal of the Federation of the American Societies for Experimental Biology 2002; 16: 213-215.
7. Wang Z, Cook T, Alber S, Liu K, Kovesdi I, Watkins SK, Vodovotz Y, Billiar TR and Blumberg D. Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation resistance of human colorectal cancer associated with alterations. Cancer Research 2004; 64: 1386-1395.
8. 2 tension measurements. Cancer Research 1991; 51: 6098-6102.
9. Krishna MC, English S, Yamada K, Yoo J, Murugesan R, Devasahayam N, Cook JA, Golman K, Ardenkjaer-Larsen JH, Subramaniam S and Mitchell JB. Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 2216-2221.
10. Mitchell JB, Wink DA, DeGraff W, Gamson J, Keefer LK and Krishna MC. Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Research 1993; 53: 5845-5848.
11. Griffin RJ, Makepeace CM, Hur WJ and Song CW. Radiosensitizing of hypoxic tumor cells in vitro by nitric oxide. International Journal of Radiation Oncology, Biology, Physics 1996; 36: 377-383.
12. Chung P, Cook T, Liu K, Vodovotz Y, Zamora R, Finkelstein S, Billiar T and Blumberg D. Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide 2003; 8: 119-126.
13. Soler MN, Bobé P, Benihoud K, Lemaire G, Roos BA and Lausson S. Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. Journal of Gene Medicine 2000; 2: 344-352.
14. Argyle DJ. Gene therapy in veterinary medicine. The Veterinary Record 1999; 144: 369-376.